Postoperative cystoid macular oedema in a patient on fingolimod
- PMID: 25969500
- PMCID: PMC4434361
- DOI: 10.1136/bcr-2015-210415
Postoperative cystoid macular oedema in a patient on fingolimod
Abstract
We describe the first case of fingolimod-associated bilateral cystoid macular oedema (CMO) following uncomplicated cataract surgery. A 57-year-old woman has been on fingolimod for the past 2 years for the treatment of relapsing-remitting multiple sclerosis. She underwent uneventful consecutive cataract surgery 2 weeks apart. Three weeks following the second cataract operation, she reported gradual-onset blurred vision bilaterally. Examination revealed mildly reduced visual acuity and bilateral CMO. Treatment with topical corticosteroids and non-steroidal anti-inflammatory eye drops, as well as cessation of fingolimod in collaboration with the neurologist, resulted in complete resolution of the CMO. Patients on fingolimod are likely to be at increased risk of developing postoperative CMO.
2015 BMJ Publishing Group Ltd.
Figures


Similar articles
-
Bilateral fingolimod-associated macular oedema development after cataract surgery.BMJ Case Rep. 2021 Jun 4;14(6):e240562. doi: 10.1136/bcr-2020-240562. BMJ Case Rep. 2021. PMID: 34088686 Free PMC article.
-
Fingolimod-associated macular oedema.BMJ Case Rep. 2017 Jun 15;2017:bcr2016218912. doi: 10.1136/bcr-2016-218912. BMJ Case Rep. 2017. PMID: 28619738 Free PMC article. No abstract available.
-
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.Mult Scler Relat Disord. 2015 Sep;4(5):406-408. doi: 10.1016/j.msard.2015.06.015. Epub 2015 Jul 2. Mult Scler Relat Disord. 2015. PMID: 26346788
-
Famous.Surv Ophthalmol. 2016 Jul-Aug;61(4):512-9. doi: 10.1016/j.survophthal.2015.12.008. Epub 2015 Dec 29. Surv Ophthalmol. 2016. PMID: 26742785 Review.
-
Cystoid macular oedema following cataract surgery: A review.Clin Exp Ophthalmol. 2019 Apr;47(3):346-356. doi: 10.1111/ceo.13513. Clin Exp Ophthalmol. 2019. PMID: 30953417 Review.
Cited by
-
Fingolimod-associated severe bilateral cystoid macular edema.Am J Ophthalmol Case Rep. 2022 Apr 22;26:101553. doi: 10.1016/j.ajoc.2022.101553. eCollection 2022 Jun. Am J Ophthalmol Case Rep. 2022. PMID: 35514796 Free PMC article.
-
Bilateral fingolimod-associated macular oedema development after cataract surgery.BMJ Case Rep. 2021 Jun 4;14(6):e240562. doi: 10.1136/bcr-2020-240562. BMJ Case Rep. 2021. PMID: 34088686 Free PMC article.
-
Fingolimod: therapeutic mechanisms and ocular adverse effects.Eye (Lond). 2017 Feb;31(2):232-240. doi: 10.1038/eye.2016.258. Epub 2016 Nov 25. Eye (Lond). 2017. PMID: 27886183 Free PMC article. Review.
-
Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.Syst Rev. 2021 Oct 28;10(1):280. doi: 10.1186/s13643-021-01782-7. Syst Rev. 2021. PMID: 34711264 Free PMC article.
-
Diagnosis and Management of Fingolimod-Associated Macular Edema.Front Neurol. 2022 Jul 15;13:918086. doi: 10.3389/fneur.2022.918086. eCollection 2022. Front Neurol. 2022. PMID: 35911881 Free PMC article.
References
-
- Chiba K, Yanagawa Y, Masubuchi Y et al. . FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998;160:5037–44. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous